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To the Editor: 
 
 
In our recently published study,1 we used administrative claims data to examine the association 
between hearing aids (HAs) and dementia among older adults with hearing loss (HL). In 2017, a 
Lancet Commission report highlighted that HL carried a greater risk of dementia than other 
potential risk factors, such as hypertension and obesity, and could be expected to have a high 
population-attributable risk due to the increasing prevalence of HL.2 The study further calculated 
that more than one third of dementia cases may be prevented by addressing risk factors across 




While randomized clinical trials may still be considered the gold standard in clinical research, 
with the availability of large datasets, observational studies are increasingly gaining momentum. 
Observational studies are inherently less expensive, include a broader patient population, are 
more efficient, and can examine longitudinal data over a relatively long period of time.3 With 
regard to potential biases, there is little evidence to support the superiority of randomized clinical 
trials over observational studies.3  
 
In our recent study, our descriptive results revealed that in aggregate, people with HAs had lower 
rates of cardiovascular conditions, hypertension, hypercholesterolemia, obesity, and diabetes at 
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the time of HL diagnosis. Abiola et al. raised a valid concern regarding a potential selection bias 
in our study.4 All studies, particularly observational studies are prone to selection biase when 
comparing different population groups. To address this, we adjusted our analytical models for 
age, sex, race/ethnicity, and chronic conditions that are more prevalent among individuals with 
HL and conducted several sensitivity analyses, including propensity score matching between 
those with and without HL. None of our sensitivity analyses qualitatively changed the results of 
our original analyses. Abiola et al. also raised a question regarding timing of the HA use.4 Since 
we were interested in the association between HAs and time to diagnosis of certain conditions, 
we included those who acquired HAs right after HL diagnosis (about 60% of HAs users). This 
made our analysis much cleaner because we were able to follow each patient for at least three 
years after the diagnosis of HL and first use of HAs. It is plausible that by excluding those who 
had fewer than three years of follow-up, we introduced some bias into our analysis. Not having 
information on why an individual is no longer covered by a health plan (i.e death, switching 
health plans, switching jobs, etc.), we examined the results for those with at least three years of 
follow-up time. The main shortcoming of our study was unavailability of information on several 
salient risk factors in our dataset. For example, we did not have information on duration and 
severity of HL, frequency of HA use, if any, socioeconomic status, and lifestyle choices of our 
patient population. Future research using other datasets should try to address the limitations of 
our study and therefore confirm or dispute our findings.   
 
This article is protected by copyright. All rights reserved.
By providing enhanced hearing input, HAs may facilitate greater social engagement, decrease 
levels of effort required to recognize sounds and speech, decrease levels of depression or anxiety, 
increase levels of physical balance, and promote greater feelings of independence and self-
efficacy.5-7 Believing in one’s physical and cognitive ability to socially engage and accomplish a 
task or participate in social events has been shown to advance cognitive functioning.  
 
The prevalence of HL is estimated to increase substantially due to our growing geriatric 
population.9 The adverse effects of HL are profound and varied, affecting individuals’ quality of 
life and their ability to perform independent activities of daily living.10 Research has shown that 
individuals with HL are at higher risk of Alzheimer’s disease and related dementias.2 Thus, it is 
of paramount importance for researchers to continue examining the effects of HAs, the default 
non-invasive treatment option for HL, on dementia and mild cognitive impairment among older 
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